Rutong B. Yu
99, West Huai Hai Road
Xuzhou, 221002, China
Xuzhou, 221002, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 129 publications
PCIF1 modulates glioblastoma cell migration and invasion by altering PI(3,4)P2 levels through the PI5-phosphatase INPP5B.
Journal: Acta biochimica et biophysica Sinica
Published: May 18, 2026
Engineered extracellular vesicles derived from sweet potato loaded with siPOLD1 for targeted therapy of glioma.
Journal: Journal of advanced research
Published: February 26, 2026
Biomimetic M2 microglia membrane-coated nanoplatform for immune reprogramming and targeted edaravone delivery in ischemic stroke.
Journal: Regenerative biomaterials
Published: February 01, 2026
Dual-targeted manganese-doped carbon dots activate the cGAS-STING pathway and immunogenic cell death for potent glioblastoma immunotherapy.
Journal: Materials today. Bio
Published: January 20, 2026
Potential anti-glioma targets and mechanisms of Smilax china L. based on network pharmacological, molecular docking and experimental verification.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: January 16, 2026
Morusinol exerts anti-glioma activity by targeting the PI3K/AKT/mTOR signaling pathway.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: December 15, 2025
Nebivolol suppresses glioblastoma progression via dual modulation of mitochondrial metabolism and AKT/mTOR/4EBP1 signaling axis.
Journal: PLoS genetics
Published: December 03, 2025
Vebreltinib for Previously Treated Astrocytoma, IDH-Mutant, Grade 4, and Glioblastoma, IDH Wild-Type with PTPRZ1-MET Fusion Gene: A Multicenter, Phase III Randomized, Open-Label Trial.
Journal: Cancer communications (London, England)
Published: November 22, 2025
Relationship between cerebrospinal fluid neurobiomarkers and symptoms in older patients with cognitive impairment: an observational clinical study.
Journal: Scientific reports
Published: November 16, 2025
Updated clinical practice guidelines for the management of adult diffuse gliomas.
Journal: Cancer letters
Published: September 03, 2025
Retraction notice to "β-Catenin is involved in Bex2 down-regulation induced glioma cell invasion/migration inhibition" [Biochem. Biophys. Res. Commun. 456 (2015) 494-499].
Journal: Biochemical and biophysical research communications
Published: August 06, 2025
Correction: β-catenin-mediated YAP signaling promotes human glioma growth.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 31, 2025
Last Updated: 09/26/2026